This news release was originally published on the Department of Defense's website.

As part of an ongoing collaboration between the Department of Health and Human Services and the Department of Defense, the two departments awarded a contract for $24.3 million to Becton, Dickinson and Company (BD) to establish and expand domestic production of SARS-CoV-2 rapid point-of-care tests.